Erasca faces patent infringement and trade secret allegations from Revolution Medicines over ERAS-0015

Erasca, Inc.

RevMed alleges ERAS-0015 infringes U.S. Patent No. 12,409,225 and misappropriated trade secrets.
Erasca believes the allegations are without merit and will vigorously contest them.
Erasca also announced a conference call at 4:30pm ET today to discuss preliminary Phase 1 data for ERAS-0015.
No data results were disclosed in this filing; only the call schedule is provided.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-179214
form_type: 8-K
ticker: ERAS
cik: 0001761918
company_name: Erasca, Inc.
filed_at: 2026-04-27T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.869758+00:00
generated_at: 2026-05-15T03:54:08.160934+00:00
sec_items: ["7.01", "8.01"]
event_type: litigation
sentiment: negative
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-179214
json_url: https://secwatch.observer/filing/0001193125-26-179214.json
markdown_url: https://secwatch.observer/filing/0001193125-26-179214.md
text_url: https://secwatch.observer/filing/0001193125-26-179214.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1761918/000119312526179214/0001193125-26-179214-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1761918/000119312526179214/eras-20260427.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

GoPro wins patent case; court vacates $8.2M award, finds all claims invalid

GoPro, Inc. May 18, 2026, 6:50 AM ET litigation Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01 same event type: litigation similar materiality

Capricor sues Nippon Shinyaku over failed Deramiocel launch preparations; seeks agreement rescission

CAPRICOR THERAPEUTICS, INC. May 7, 2026, 7:59 PM ET litigation Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01 same event type: litigation similar materiality

Roivant's Genevant/Arbutus settles Moderna LNP patent suit for $950M upfront, plus $1.3B contingent

Roivant Sciences Ltd. March 3, 2026, 6:59 PM ET litigation Items 1.01, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01 same event type: litigation similar materiality

Court denies preliminary injunction against Perpetua's Stibnite Gold Project; construction resumes

PERPETUA RESOURCES CORP. June 1, 2026, 7:40 AM ET litigation Items 8.01